Inoperable de novo metastatic colorectal cancer with primary tumour in situ: Evaluating discordant responses to upfront systemic therapy of the primary tumours and metastatic sites and complications arising from primary tumours (experiences from an Irish Cancer Centre)

Systemic therapy is the mainstay of treatment for de novo metastatic colorectal cancer (mCRC). Heterogeneity between primary tumours and metastases may lead to discordant responses to systemic therapy at these sites. The aim of the present study was to examine these discrepancies and to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamed, Ruba A., Marks, Sam, Mcelligott, Helen, Kalachand, Roshni, Ibrahim, Hawa, Atyani, Said, Korpanty, Greg, Osman, Nemer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739439/
https://www.ncbi.nlm.nih.gov/pubmed/35003738
http://dx.doi.org/10.3892/mco.2021.2472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739439/
https://www.ncbi.nlm.nih.gov/pubmed/35003738
http://dx.doi.org/10.3892/mco.2021.2472

Ejemplares similares